Peter Evan Harwin - Net Worth and Insider Trading

Over the past 18 months, Peter Evan Harwin made no insider transaction in Cogent Biosciences Inc (COGT). Other recent insider transactions involving Cogent Biosciences Inc (COGT) include a net purchase of 800,000 shares made by Fairmount Funds Management Llc ,

In summary, during the past 3 months, insiders sold 0 shares of Cogent Biosciences Inc (COGT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cogent Biosciences Inc (COGT) were sold and 800,000 shares were bought by its insiders, resulting in a net purchase of 800,000 shares.

Cogent Biosciences Inc (COGT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Peter Evan Harwin made no insider transaction in Mirati Therapeutics Inc (MRTX). Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 8,522 shares made by Jamie Christensen , a net sale of 5,907 shares made by Benjamin Hickey , and a net purchase of 2,517,946 shares made by Boxer Capital, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,076 shares of Mirati Therapeutics Inc (MRTX) were sold and 2,528,737 shares were bought by its insiders, resulting in a net purchase of 2,509,661 shares.

Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Peter Evan Harwin made no insider transaction in Viridian Therapeutics Inc (VRDN). Other recent insider transactions involving Viridian Therapeutics Inc (VRDN) include a net sale of 9,796 shares made by Lara Meisner , a net purchase of 1,600,000 shares made by Fairmount Healthcare Fund Ii Gp Llc , and a net purchase of 476,190 shares made by Fairmount Healthcare Fund Gp Llc .

In summary, during the past 3 months, insiders sold 0 shares of Viridian Therapeutics Inc (VRDN) in total and bought 1,626,400 shares, with a net purchase of 1,626,400 shares. During the past 18 months, 9,796 shares of Viridian Therapeutics Inc (VRDN) were sold and 2,102,590 shares were bought by its insiders, resulting in a net purchase of 2,092,794 shares.

Viridian Therapeutics Inc (VRDN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Peter Evan Harwin made no insider transaction in Spyre Therapeutics Inc (SYRE). Other recent insider transactions involving Spyre Therapeutics Inc (SYRE) include a net sale of 18,531 shares made by Scott L Burrows , and a net sale of 300 shares made by Jeffrey W. Albers .

In summary, during the past 3 months, insiders sold 18,831 shares of Spyre Therapeutics Inc (SYRE) in total and bought 0 shares, with a net sale of 18,831 shares. During the past 18 months, 18,831 shares of Spyre Therapeutics Inc (SYRE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 18,831 shares.

Spyre Therapeutics Inc (SYRE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Peter Evan Harwin made no insider transaction in Apogee Therapeutics Inc (APGE). Other recent insider transactions involving Apogee Therapeutics Inc (APGE) include a net sale of 135,000 shares made by Michael Thomas Henderson , a net sale of 26,660 shares made by Carl Dambkowski , and a net purchase of 2,941,176 shares made by Fairmount Healthcare Fund L.p. .

In summary, during the past 3 months, insiders sold 146,665 shares of Apogee Therapeutics Inc (APGE) in total and bought 0 shares, with a net sale of 146,665 shares. During the past 18 months, 167,660 shares of Apogee Therapeutics Inc (APGE) were sold and 4,691,176 shares were bought by its insiders, resulting in a net purchase of 4,523,516 shares.

Apogee Therapeutics Inc (APGE)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Magenta Therapeutics Inc (MGTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Magenta Therapeutics Inc (MGTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Magenta Therapeutics Inc (MGTA)'s detailed insider trading history can be found in Insider Trading Tracker table.